Keywords: chiroscience, d3967, news, been, given, go-ahead, begin

Chiroscience : D3967 news

Article | 22 January 1996

Print This

- Chiroscience has been given the go-ahead to begin Phase II clinical studies of D3967, a singe-isomer version of ifosfamide for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in